Cargando…
Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients—a perspective
Autores principales: | Hammarström, Lennart, Abolhassani, Hassan, Baldanti, Fausto, Marcotte, Harold, Pan-Hammarström, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215168/ https://www.ncbi.nlm.nih.gov/pubmed/32413374 http://dx.doi.org/10.1016/j.jaci.2020.04.043 |
Ejemplares similares
-
Passive Immunization: Toward Magic Bullets
por: Marcotte, Harold, et al.
Publicado: (2015) -
Antibody therapy for COVID-19
por: Hammarström, Lennart, et al.
Publicado: (2021) -
SARS-CoV-2 infection in patients with inborn errors of immunity due to DNA repair defects: DNA repair deficiency and COVID19
por: Wang, Yating, et al.
Publicado: (2022) -
Hallmarks of Cancers: Primary Antibody Deficiency Versus Other Inborn Errors of Immunity
por: Abolhassani, Hassan, et al.
Publicado: (2021) -
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
por: Marcotte, Harold, et al.
Publicado: (2022)